Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Saito (Tokyo, Japan), J. Araya (Tokyo, Japan), A. Ito (Tokyo, Japan), Y. Hosaka (Tokyo, Japan), A. Ichikawa (Tokyo, Japan), T. Kadota (Tokyo, Japan), T. Nakano (Tokyo, Japan), M. Yoshida (Tokyo, Japan), Y. Fujita (Tokyo, Japan), H. Utsumi (Tokyo, Japan), M. Hashimoto (Tokyo, Japan), H. Wakui (Tokyo, Japan), S. Minagawa (Tokyo, Japan), H. Hara (Tokyo, Japan), T. Numata (Tokyo, Japan), Y. Kaneko (Tokyo, Japan), K. Kuwano (Tokyo, Japan). Lysosomal dysfunction in COPD pathogenesis.. 1673

Member's Comments

No comment yet.

Related content which might interest you: Mitochondrial dysfunction in chronic lung disease Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease Year: 2016 Macrophage dysfunction in the pathogenesis and treatment of asthma Source: Eur Respir J, 50 (3) 1700196; 10.1183/13993003.00196-2017 Year: 2017 PARK2-regulated mitophagy in COPD pathogenesis Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD Source: ERS Lung Science Conference 2020 Year: 2020 Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference Year: 2020 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Involvement ferroptosis in COPD pathogenesis Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Defective metabolic adaptation in the pathogenesis of COPD Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 ERICA (evaluating the role of inflammation in chronic airways disease): Extrapulmonary manifestations of COPD Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Role of diaphragm dysfunction and nutritional status on dyspnea pathogenesis in patients with COPD. Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Mitochondrial dysfunction in lung ageing and disease Source: Eur Respir Rev, 29 (157) 200165; 10.1183/16000617.0165-2020 Year: 2020 Endotelialny dysfunction at patients with COPD and coronary heart disease Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014